Search Results - "Ståhle, M"

The psoriasis area and severity index is an independent risk factor for cardiovascular events: A prospective register study by Svedbom, A, Ståhle, M

“…Patients treated with systemics for moderate-to-severe psoriasis have increased risk of cardiovascular disease (CVD). However, to the best of our knowledge,…”
Get full text

Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach by Hedin, C.R.H., Sonkoly, E., Eberhardson, M., Ståhle, M.

“…Psoriasis and inflammatory bowel disease (IBD) are immune‐mediated diseases occurring in barrier organs whose main task is to protect the organism from attack…”
Get full text

Commentary to “Clinical characteristics including cardiovascular and metabolic risk factors in adolescents with psoriasis” by C Blegvad et al by Stahle, M

“…Linked article: C. Blegvad et al. J Eur Acad Dermatol Venereol 2020; 34: 1516–1523. https://doi.org/10.1111/jdv.16229…”
Get full text

Real‐world comparative effectiveness of adalimumab, etanercept and methotrexate: a Swedish register analysis by Svedbom, A., Ståhle, M.

“…Background The advent of biosimilars may render etanercept (ETN) and adalimumab (ADA) viable alternatives to methotrexate (MTX) as first‐line systemics in…”
Get full text

Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis by Pasquali, L., Svedbom, A., Srivastava, A., Rosén, E., Lindqvist, U., Ståhle, M., Pivarcsi, A., Sonkoly, E.

“…Background Psoriatic arthritis (PsA) develops in ~30% of patients with psoriasis. The diagnosis of PsA is challenging, and there are no reliable molecular…”
Get full text

Retraction Note: Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor by Girnita, A., Zheng, H., Grönberg, A., Girnita, L., Ståhle, M.

Get full text

MicroRNAs: novel regulators in skin inflammation by Sonkoly, E., Ståhle, M., Pivarcsi, A.

“…Summary Compelling evidence indicates that microRNAs (miRNAs), short, non‐protein coding RNAs, are critical for the development and survival of multicellular…”
Get full text

Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-α therapy by Pivarcsi, A., Meisgen, F., Xu, N., Ståhle, M., Sonkoly, E.

“…Summary Background MicroRNAs (miRNAs) are endogenous, nonprotein‐coding, regulatory RNAs with important roles in health and disease. miRNAs are present in the…”
Get full text

Can treatment of the skin rescue the heart? by Stahle, M

Get full text

Treatment patterns with topicals, traditional systemics and biologics in psoriasis - a Swedish database analysis by Svedbom, A., Dalén, J., Mamolo, C., Cappelleri, J.C., Petersson, I.F., Ståhle, M.

“…Background Little data exist on real‐world treatment patterns in psoriasis, especially from European settings. Objective To estimate, for topicals, systemics…”
Get full text

Drug concentration and antidrug antibodies in patients with psoriasis treated with adalimumab or etanercept by Gyldenløve, M., Zachariae, C., Jensen, P., Griehsel, H., Ståhle, M., Skov, L.

Get full text

Microscopic Colitis and Risk of Incident Psoriasis: A Nationwide Population-Based Matched Cohort Study by Bergman, David, Roelstraete, Bjorn, Sun, Jiangwei, Ebrahimi, Fahim, Lidström, Rickard, Svedbom, Axel, Ståhle, Mona, Ludvigsson, Jonas F

“…Microscopic colitis (MC) has been associated with several immune-mediated diseases including psoriasis, but earlier research has been limited to psoriasis…”
Get full text

Disease activity in and quality of life of patients with psoriatic arthritis mutilans: the Nordic PAM Study by Lindqvist, U, Gudbjornsson, B, Iversen, L, Laasonen, L, Ejstrup, L, Ternowitz, T, Ståhle, M

“…Objective: To describe the social status and health-related quality of life of patients with psoriatic arthritis mutilans (PAM) in the Nordic countries…”
Get full text

MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma by Sonkoly, E, Lovén, J, Xu, N, Meisgen, F, Wei, T, Brodin, P, Jaks, V, Kasper, M, Shimokawa, T, Harada, M, Heilborn, J, Hedblad, M-A, Hippe, A, Grandér, D, Homey, B, Zaphiropoulos, P G, Arsenian-Henriksson, M, Ståhle, M, Pivarcsi, A

“…Basal cell carcinoma (BCC) of the skin represents the most common malignancy in humans. MicroRNAs (miRNAs), small regulatory RNAs with pleiotropic function,…”
Get full text

Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans by Wang, Sailan, Nikamo, Pernilla, Laasonen, Leena, Gudbjornsson, Bjorn, Ejstrup, Leif, Iversen, Lars, Lindqvist, Ulla, Alm, Jessica J, Eisfeldt, Jesper, Zheng, Xiaowei, Catrina, Sergiu-Bogdan, Taylan, Fulya, Vaz, Raquel, Ståhle, Mona, Tapia-Paez, Isabel

“…Psoriatic arthritis mutilans (PAM) is the rarest and most severe form of psoriatic arthritis, characterized by erosions of the small joints and osteolysis…”
Get full text

Psoriatic arthritis mutilans (PAM) in the Nordic countries: demographics and disease status. The Nordic PAM study by Gudbjornsson, B, Ejstrup, L, Gran, JT, Iversen, L, Lindqvist, U, Paimela, L, Ternowitz, T, Ståhle, M

“…Objective: To determine the prevalence and clinical characteristics of psoriatic arthritis mutilans (PAM) in the Nordic countries.Method: Patients with…”
Get full text

Human islet separation utilizing a closed automated purification system by Friberg, A S, Ståhle, M, Brandhorst, H, Korsgren, O, Brandhorst, D

“…A central step within the human islet isolation process is the separation of islets from contaminating exocrine tissue utilizing linear, continuous density…”
Get full text

Photochemical pathogen inactivation of human serum enables its large-scale application in clinical cell transplantation by Ståhle, M., Carlsson, B., Le Blanc, K., Korsgren, O., Knutson, F.

Get full text

RETRACTED ARTICLE:Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor by Girnita, A, Zheng, H, Grönberg, A, Girnita, L, Ståhle, M

“…The human cathelicidin antimicrobial protein-18 and its C terminal peptide, LL-37, displays broad antimicrobial activity that is mediated through direct…”
Get full text

Cornulin, a marker of late epidermal differentiation, is down-regulated in eczema by Liedén, A, Ekelund, E, Kuo, I.-C, Kockum, I, Huang, C.-H, Mallbris, L, Lee, S.P, Seng, L.K, Chin, G.Y, Wahlgren, C.-F, Palmer, C.N.A, Björkstén, B, Ståhle, M, Nordensköld, M, Bradley, M, Chua, K.Y, D'Amato, M

“…Eczema is a common chronic inflammatory skin disorder which shows strong genetic predisposition. To identify new potential molecular determinants of the…”
Get full text